| Symbol | EMBC |
|---|---|
| Name | EMBECTA CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 300 KIMBALL DRIVE,SUITE 300, PARSIPPANY, New Jersey, 07054, United States |
| Telephone | +1 862 - 401-0000 |
| Fax | — |
| — | |
| Website | https://www.embecta.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001872789 |
| Description | Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Additional info from NASDAQ: |
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC
Read moreEMBC INVESTOR ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Read moreSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBC
Read moreEmbecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC
Read moreEMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law
Read moreEMBC INVESTOR ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Read moreEMBC UPCOMING DEADLINE : The Gross Law Firm Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm
Read moreEmbecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT06692153 | Embecta AID System in Adults With Type 2 Diabetes | Na | Type 2 Diabetes | Withdrawn | 2025-01-01 | 2026-05-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Standard of Care (SC) | Other | Approved | Type 2 Diabetes | WITHDRAWN | NCT06692153 |
| An AID System. | Other | Approved | Type 2 Diabetes | WITHDRAWN | NCT06692153 |
| Standard of Care (SC) | OTHER | Approved | Type 2 Diabetes | WITHDRAWN | NCT06692153 |
| An AID System. | DEVICE | Approved | Type 2 Diabetes | WITHDRAWN | NCT06692153 |